143 related articles for article (PubMed ID: 2764537)
1. Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.
Welage LS; Hejmanowski LG; Wilton JH; Walawander C; Rigan D; Williams JS; Schentag JJ
Antimicrob Agents Chemother; 1989 Jun; 33(6):857-61. PubMed ID: 2764537
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole.
Welage LS; Borin MT; Wilton JH; Hejmanowski LG; Wels PB; Schentag JJ
Antimicrob Agents Chemother; 1990 Dec; 34(12):2369-74. PubMed ID: 2088192
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety.
Schentag JJ; Welage LS; Williams JS; Wilton JH; Adelman MH; Rigan D; Grasela TH
Am J Surg; 1988 May; 155(5A):40-4. PubMed ID: 3163900
[TBL] [Abstract][Full Text] [Related]
4. Determinants of antibiotic-associated hypoprothrombinemia.
Schentag JJ; Welage LS; Grasela TH; Adelman MH
Pharmacotherapy; 1987; 7(3):80-6. PubMed ID: 3306622
[TBL] [Abstract][Full Text] [Related]
5. Disposition of moxalactam and N-methyltetrazolethiol in rats and monkeys.
Mizojiri K; Norikura R; Takashima A; Tanaka H; Yoshimori T; Inazawa K; Yukawa T; Okabe H; Sugeno K
Antimicrob Agents Chemother; 1987 Aug; 31(8):1169-76. PubMed ID: 3631941
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis.
Park GH; Kim S; Kim MS; Yu YM; Kim GH; Lee JS; Lee E
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623191
[TBL] [Abstract][Full Text] [Related]
7. [Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Schäfer H; Naber K; Adam D
Arzneimittelforschung; 1989 Sep; 39(9):1156-62. PubMed ID: 2590268
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the rate of 14CO2 production from [14C]ethanol in rats given beta-lactam antibiotics with disulfiram-like effects.
Turcan RG; MacDonald CM; Ings RM; Coombes JD
Antimicrob Agents Chemother; 1985 Apr; 27(4):535-40. PubMed ID: 3923923
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of latamoxef and N-methyltetrazolethiol in rats associated with the development of disulfiram-like effects.
Matsubara T; Otsubo S; Ogawa A; Oka T
Jpn J Pharmacol; 1987 Oct; 45(2):223-32. PubMed ID: 3437591
[TBL] [Abstract][Full Text] [Related]
10. Penetration and clearance of cefoperazone and moxalactam in pleural fluid.
Yamada H; Iwanaga T; Nakanishi H; Yamaguchi M; Iida K
Antimicrob Agents Chemother; 1985 Jan; 27(1):93-5. PubMed ID: 3985598
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Jones RN; Wilson HW
Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
[TBL] [Abstract][Full Text] [Related]
13. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan.
Kaiser CW; McAuliffe JD; Barth RJ; Lynch JA
Arch Surg; 1991 Apr; 126(4):524-5. PubMed ID: 1901205
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazole.
Ganzinger U; Schatz F; Haberl H; Haslberger A; Schiel H; Hitzenberger G
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):152-6. PubMed ID: 3557743
[TBL] [Abstract][Full Text] [Related]
16. Biliary excretion of latamoxef and N-methyltetrazolethiol in humans and rats.
Uchida K; Konishi M; Akiyoshi T; Igimi H; Asakawa S
J Pharmacobiodyn; 1985 Nov; 8(11):981-8. PubMed ID: 4093852
[TBL] [Abstract][Full Text] [Related]
17. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
Barriere SL; Ozasa DC; Mordenti J
Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680
[TBL] [Abstract][Full Text] [Related]
18. Diffusibility of the newer cephalosporins into human interstitial fluids.
Tan JS; Salstrom SJ; File TM
Am J Med; 1984 Oct; 77(4C):33-6. PubMed ID: 6093516
[TBL] [Abstract][Full Text] [Related]
19. The effects of 1-methyl-5-thiotetrazole in a rat liver vitamin K-dependent carboxylase assay.
Smith GF; Sundboom JL
Thromb Res; 1984 Mar; 33(6):633-44. PubMed ID: 6719405
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
Shearer MJ; Bechtold H; Andrassy K; Koderisch J; McCarthy PT; Trenk D; Jähnchen E; Ritz E
J Clin Pharmacol; 1988 Jan; 28(1):88-95. PubMed ID: 3350995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
